{
    "id": 24086,
    "fullName": "PARP2 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PARP2 dec exp indicates decreased expression of the Parp2 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10038,
        "geneSymbol": "PARP2",
        "terms": [
            "PARP2",
            "ADPRT2",
            "ADPRTL2",
            "ADPRTL3",
            "ARTD2",
            "pADPRT-2",
            "PARP-2"
        ]
    },
    "variant": "dec exp",
    "createDate": "07/08/2016",
    "updateDate": "07/08/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7275,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, inhibition of Parp2 via shRNA enhanced Adriamycin (doxorubicin) induced tumor growth inhibition in cell line xenograft models of hepatocellular carcinoma (PMID: 27300349).",
            "molecularProfile": {
                "id": 24817,
                "profileName": "PARP2 dec exp"
            },
            "therapy": {
                "id": 1009,
                "therapyName": "Doxorubicin",
                "synonyms": null
            },
            "indication": {
                "id": 684,
                "name": "hepatocellular carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6270,
                    "pubMedId": 27300349,
                    "title": "The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27300349"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24817,
            "profileName": "PARP2 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}